Catch up on the most well-viewed magnetic resonance imaging (MRI) content from 2024.
As we come to the end of 2024, we take a look back at the most well-read magnetic resonance imaging (MRI) imaging content with topics ranging from advanced neuroimaging for high-grade gliomas to the potential of MRI for active surveillance decisions for patients with intermediate risk prostate cancer. Review the slideshow below to see highlighted MRI content from the past year.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.